Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest vs COC for Symptomatic Adenomyosis
NCT03654144Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Nov 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of dienogest in adenomyosis (2 arms), sponsored by Assiut University. Primary endpoint: Mean pain score at 6 months. Status: unknown.
02
Drugs
dienogest
03
Conditions
adenomyosis
Beyond the preview
Go deeper on NCT03654144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03654144.